TrialCancer immunology, immunotherapy : CII2018

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.

Jitka Fucikova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.